LB15. Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017–18 Influenza Season in Northern California

BACKGROUND: In June 2018, the CDC reported that influenza vaccine effectiveness (VE) against A(H3N2) influenza virus for the 2017–2018 season was ~24%. This lower than expected VE was hypothesized to be partially related to genetic changes arising in the vaccine virus during passage in eggs. Flucelv...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Nicola P, Fireman, Bruce, Goddard, Kristin, Zerbo, Ousseny, Asher, Jason, Zhou, James, King, James, Lewis, Ned
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253641/
http://dx.doi.org/10.1093/ofid/ofy229.2189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253641/
http://dx.doi.org/10.1093/ofid/ofy229.2189

Ejemplares similares